Sexual Dimorphism of Skeletal Muscle in a Mouse Model of Breast Cancer: A Functional and Molecular Analysis
L. E. Rentz, M. Whetsell, S. A. Clayton, A. D. Mizner, I. Holaskova, M. G. Chapa, E. H. Hoblitzell, T. D. Eubank, E. E. Pistilli
Abstract
1.Breast cancer incidence in men is statistically rare; however, given the lack of screening in males, more advanced stages at initial diagnosis results in lower 5-year survival rates for men with breast cancer compared to women. A sexual dimorphism, with respect to the effect of tumor growth on cachexia incidence and severity, has also been reported across cancer types. The purpose of this study was to examine the sexual dimorphism of breast cancer as it pertains to skeletal muscle function and molecular composition. Using female and male transgenic PyMT mice, we tested the hypothesis that isometric contractile properties and molecular composition of skeletal muscle would be differentially affected by breast tumors. PyMT tumor-bearing mice of each sex, corresponding to maximal tumor burden, were compared to their respective controls. RNA-sequencing of skeletal muscle revealed different pathway alterations that were exclusive to each sex. Further, differentially expressed genes and pathways were substantially more abundant in female tumor mice, with only minimal dysregulation in male tumor mice, each compared to their respective controls. These differences in the transcriptome were mirrored in isometric contractile properties, with greater tumor-induced dysfunction in females than male mice, as well as muscle wasting. Collectively, these data support the concept of sexually dimorphic responses to cancer in skeletal muscle and suggest these responses may be associated with the clinical differences in breast cancer between the sexes. The identified sex-dependent pathways within muscle of male and female mice provide a framework to evaluate therapeutic strategies targeting tumor-associated skeletal muscle alterations. Statement of significanceThe PyMT mouse model of breast cancer, which recapitulates clinical characteristics, exhibits differences in molecular and functional responses of skeletal muscle that are sex-dependent.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype
H. E. Wilson, D. A. Stanton, … E. E. Pistilli·bioRxiv·Oct 21, 2019
- The Time-Course of Cancer Cachexia Onset Reveals Biphasic Transcriptional Disruptions in Female Skeletal Muscle Distinct from Males
Francielly Morena da Silva, Seongkyun Lim, … Nicholas Perry Greene·BMC GenomicsPeer-reviewed·Jul 4, 2023
- Myofiber-specific FoxP1 knockout protects against pancreatic cancer-induced muscle wasting in male but not female mice.
Martin M. Schonk, Jeremy B. Ducharme, … Andrew R. Judge·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Nov 15, 2024
- Cancer cachexia overrides sex-specific traits in Drosophila
Alexia Rivero, Margaux Techer, … Cédric Polesello·bioRxiv·Oct 15, 2026
- Breast cancer-secreted factors induce atrophy and reduce basal and insulinstimulated glucose uptake by inhibiting Rac1 activation in rat myotubes
M. S. Ali, S. Bitsch-Olsen, … L. Sylow·bioRxiv·Jan 27, 2020
- Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG
H. E. Wilson, D. A. Stanton, E. E. Pistilli·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Apr 1, 2021